🔑 Key Takeaways
- PT-141 (bremelanotide) works through the melanocortin pathway in the brain — fundamentally different from Viagra/Cialis
- It addresses desire and arousal, not just blood flow — making it effective for people who don't respond to PDE5 inhibitors
- Ascension Peptides carries PT-141 at 10mg with batch-specific COAs and US-based shipping
- Starting dose is typically 0.5-1mg subcutaneous, with most people finding their sweet spot at 1-2mg
PT-141 has a weird origin story. It started as a tanning peptide — Melanotan II, specifically — and during early trials, participants kept reporting an unexpected side effect: significantly increased sexual arousal. Researchers eventually isolated the part of the molecule responsible for the sexual effects, stripped out the tanning components, and created bremelanotide — what we now call PT-141.
That accidental discovery turned into Vyleesi, an FDA-approved medication for hypoactive sexual desire disorder in women (approved in 2019). But the peptide version — PT-141 — has found a much wider audience among both men and women who want an alternative to the usual options. And unlike Viagra, Cialis, and the rest of the PDE5 inhibitor family, PT-141 doesn't just address the plumbing. It addresses desire itself.
If you're looking for PT-141 for sale from a source you can actually trust, Ascension Peptides carries it at 10mg per vial — batch-specific COAs, 99%+ purity, US-based shipping. They keep it consistently in stock, which matters because PT-141 availability has been spotty at other suppliers throughout 2025-2026. But before you buy, let me walk you through exactly how this compound works and what to expect.
What PT-141 Does: The Melanocortin Pathway
Most sexual function compounds work peripherally — they increase blood flow to the genitals. PT-141 works centrally. It activates melanocortin receptors (specifically MC3R and MC4R) in the hypothalamus, the part of your brain that regulates sexual desire, arousal, and motivation.
This is a fundamentally different mechanism. Viagra doesn't make you want sex — it makes the physical response possible once you're already aroused. PT-141 acts upstream of that. It influences the neurological pathway that generates desire in the first place. For people whose issue is "I can get an erection but I just don't feel like it," or "physically everything works but the drive isn't there," this distinction matters enormously.
The practical result? People report a noticeable increase in sexual desire, heightened sensitivity to touch, stronger physiological arousal responses, and more intense experiences overall. Both men and women report these effects, which makes sense given that the melanocortin pathway isn't gender-specific — it's a fundamental part of human neurobiology.
Why People Are Choosing PT-141 Over Traditional Options
The surge in PT-141 interest isn't random. It's driven by specific limitations of the alternatives:
PDE5 inhibitors (Viagra, Cialis) don't work for everyone. An estimated 30-40% of men with erectile dysfunction don't respond adequately to sildenafil or tadalafil. For these non-responders, PT-141 offers a completely different mechanism that may succeed where PDE5 inhibitors failed.
Cardiovascular concerns. PDE5 inhibitors affect blood pressure and interact dangerously with nitrates. People with certain cardiac conditions can't use them safely. PT-141 doesn't operate through the cardiovascular system at all — no blood pressure effects, no nitrate interactions, no cardiac risk profile to worry about.
Women have had virtually no options. Viagra doesn't work well for female sexual dysfunction. Flibanserin (Addyi) has modest efficacy with significant side effects and daily dosing requirements. PT-141 works on-demand for both sexes, acting on the same neural pathway regardless of gender. The FDA approval of Vyleesi (the branded version) specifically for women speaks to this unmet need.
The "desire gap" problem. Many people — particularly those on SSRIs, post-menopausal women, men with age-related decline, people under chronic stress — experience diminished desire even when the physical hardware works fine. PT-141 is virtually the only compound that targets this specific issue.
PT-141 vs Viagra: The Real Comparison
Since this is the comparison everyone's thinking about, let me lay it out clearly:
The key insight: these aren't really competitors. They work through entirely different pathways and address different problems. Someone with purely mechanical ED (blood flow issue) might do better with Viagra. Someone whose issue is low desire, SSRI-induced anhedonia, or arousal that just doesn't happen like it used to — PT-141 is the more logical choice. And some people use both, addressing both the desire and the physical response simultaneously.
Where to Buy PT-141: Why Ascension Peptides
Finding PT-141 for sale from a trustworthy source has gotten harder in 2026, not easier. Several suppliers that used to carry it have either dropped it from their catalogs or have chronic stock issues. Part of this is demand — PT-141 interest has exploded. Part of it is that quality synthesis of bremelanotide isn't trivial, and not every supplier has the manufacturing relationships to keep it in stock.
Ascension Peptides stocks PT-141 at 10mg per vial. Here's what matters:
- Consistent availability — they maintain stock, not the "check back next week" experience you get elsewhere
- 10mg vial size — at typical dosing of 1-2mg per use, a single vial provides 5-10 uses. Practical sizing for on-demand use
- Batch-specific COAs — third-party HPLC and mass spec confirmation. You know exactly what's in your vial
- 99%+ purity — critical for an injectable compound you're trusting to work correctly
- US-based shipping — fast, reliable, properly handled
The 10mg sizing is actually smart for PT-141 specifically. Unlike daily-use peptides where you burn through a vial in a week, PT-141 is used on-demand — maybe once or twice a week at most. A 10mg vial at 1.5mg per use gives you 6-7 uses, which for most people is 3-7 weeks of supply depending on frequency. Enough to get real experience with the compound without overcommitting financially.
PT-141 Dosing: Where to Start
Dosing PT-141 correctly makes a huge difference in both effectiveness and side effects. Too low and you feel nothing. Too high and you spend the evening nauseous instead of enjoying the effects. Here's the protocol most people follow:
Start at 0.5mg. I know it's tempting to jump to the "standard" dose, but PT-141's side effects (primarily nausea) are dose-dependent, and individual sensitivity varies dramatically. Some people get strong effects from 0.5mg. Others need 2mg. You won't know where you fall until you try, and starting low gives you room to titrate up without an unpleasant first experience.
Timing matters. Inject subcutaneously 45-60 minutes before you want the effects to kick in. Some people report onset as fast as 20-30 minutes; others take a full hour. Plan accordingly. And don't redose if you don't feel anything at the 60-minute mark — give it the full 90 minutes before concluding the dose wasn't enough.
Don't use more than once every 24 hours. And most experienced users space doses at least 48-72 hours apart. Frequent use can lead to diminished response (tachyphylaxis) and increased nausea. PT-141 works best as an occasional tool, not a daily supplement.
For the complete dosing breakdown including how to reconstitute, injection technique, and week-by-week protocols, see our PT-141 dosage guide.
What to Expect: Real Effects and Timeline
Let me set honest expectations because the internet is full of exaggerated PT-141 claims:
What most people experience (at an appropriate dose):
- Noticeable increase in sexual desire starting 30-60 minutes after injection
- Heightened sensitivity to touch — things feel more… electric. There's no better word for it
- Stronger and more spontaneous physical arousal responses
- More intense experiences overall — both men and women report this consistently
- Effects lasting 2-6 hours at peak, with residual enhancement up to 12 hours
What PT-141 is NOT:
- Not a guarantee of erection (though many men report significant improvement in this area)
- Not aphrodisiac in the sense that you'll be uncontrollably aroused — it heightens desire, it doesn't override your will
- Not effective if you take it and then sit alone doing nothing — like any pro-desire compound, it works best in the context of actual intimacy or stimulation
Side effects to expect: Mild nausea is the most common side effect, especially at higher doses or during first-time use. Facial flushing is common (and usually brief). Some people get a headache. These side effects typically diminish with subsequent uses as your body adjusts. If nausea is an issue, taking an anti-nausea supplement 30 minutes before PT-141 can help significantly.
Side Effects and Safety Considerations
PT-141 has a well-documented side effect profile, partly because the branded version (Vyleesi) went through full FDA clinical trials. Here's what the data shows:
The nausea is the big one. At clinical trial doses (1.75mg), about 40% of participants experienced nausea. But here's the thing — it's strongly dose-dependent and tends to decrease over time. Most people who start at 0.5mg and gradually increase experience significantly less nausea than those who jump straight to 1.75mg or 2mg.
For the full safety profile including contraindications and interactions, check our PT-141 side effects guide.
How to Verify Quality When Buying PT-141
PT-141 is one of the more commonly counterfeited or substituted peptides, partly because of its popularity and partly because the effects are subjective enough that buyers might not immediately realize they got a bad product. Here's how to protect yourself:
COA Verification
The COA should show HPLC purity above 98%, mass spectrometry confirming the molecular weight of bremelanotide (1025.2 Da), and a batch number matching your vial. If the COA shows a molecular weight that doesn't match, or if HPLC purity is below 95%, walk away.
Physical Inspection
Lyophilized PT-141 should be a white to off-white powder or cake. Yellow or brown discoloration indicates degradation. The vial should be properly sealed with an aluminum crimp and a clean label with lot information.
Reconstitution Test
When you add bacteriostatic water, PT-141 should dissolve completely within a few minutes of gentle swirling. If the solution is cloudy, has visible particles, or the powder doesn't fully dissolve, the product may be degraded or improperly manufactured.
Effect Verification
At an appropriate dose (1-2mg), PT-141 should produce noticeable effects within 60 minutes. If you've used a proper dose from a known-good source before, you have a baseline comparison. No effect at all — not even mild nausea or flushing — from a 1.5mg+ dose suggests the product isn't genuine or has degraded.
Red Flags When Buying PT-141 Online
The popularity of PT-141 has attracted its share of bad actors. Watch for these:
- "Oral PT-141" or "PT-141 nasal spray" — bremelanotide has poor bioavailability through oral and nasal routes. These are almost certainly underdosed or ineffective. Injectable is the established route
- Pre-mixed "ready to inject" PT-141 — peptides should be sold lyophilized. Pre-mixed products have unknown stability and could contain anything
- PT-141 marketed as "herbal" or "natural" — PT-141 is a synthetic peptide. Any "natural" version isn't PT-141
- Prices below $25 for 10mg — PT-141 synthesis isn't cheap. Dramatically low prices mean corners were cut
- Vendors who can't provide a COA — or provide one without batch numbers or from an unrecognizable testing lab
- Sold alongside obviously fake products — if the same shop is selling "liquid Viagra" and "testosterone drops," their PT-141 isn't going to be any more legitimate
PT-141 for Men vs Women
One of PT-141's most interesting characteristics is that it works across genders — because the melanocortin pathway is a fundamental part of human neurobiology, not gender-specific. But there are some practical differences:
For Men
PT-141 addresses both desire and physical response. Many men report improved erection quality alongside increased libido, making it uniquely effective for the "I can get hard but I don't really want to" pattern that's common with age, stress, and especially SSRI use. It's not a direct replacement for Viagra in cases of purely vascular ED, but for the majority of men whose situation involves reduced desire as a component, PT-141 often outperforms PDE5 inhibitors.
Our peptides for erectile dysfunction guide covers the full range of options for men.
For Women
This is where PT-141 really fills a gap. Female sexual dysfunction — particularly hypoactive sexual desire disorder (HSDD) — has had essentially no good treatment options until recently. The FDA approved Vyleesi (bremelanotide) specifically for this indication. Women using PT-141 commonly report increased desire, improved arousal and sensitivity, more satisfying experiences, and — perhaps most importantly — feeling like their body is "on" again after periods of low or absent desire.
For more on peptide options for sexual health, see our best peptides for libido guide.
Reconstitution and Storage
PT-141 is sold lyophilized (freeze-dried) and needs to be reconstituted before use. Here's the practical guide:
Gather Supplies
You'll need the PT-141 vial, bacteriostatic water (Ascension sells 10ml vials), an insulin syringe, and alcohol swabs.
Add Bacteriostatic Water
For a 10mg vial, add 2ml of bacteriostatic water. This gives you a concentration of 5mg/ml, or 0.5mg per 10 units on an insulin syringe. Easy math, easy dosing.
Dissolve Gently
Direct the water stream along the inside wall of the vial — don't blast it onto the powder. Swirl gently until fully dissolved. Never shake. The solution should be clear and colorless.
Store Properly
Refrigerate immediately. Reconstituted PT-141 is stable for 4-6 weeks in the fridge. Label the vial with the reconstitution date so you know when to discard it.
💡 Pro Tip
With 2ml of bac water in a 10mg vial: 10 units on your syringe = 0.5mg. So a 1mg dose = 20 units, 1.5mg = 30 units, 2mg = 40 units. Write this on the vial cap with a marker so you don't have to do math when you're in the moment.
PT-141 and SSRIs: A Particular Use Case
This deserves its own section because it's one of the most compelling applications for PT-141, and one that doesn't get enough attention.
SSRIs (selective serotonin reuptake inhibitors) are among the most widely prescribed medications in the world. And their most common and persistent side effect? Sexual dysfunction. Decreased desire, difficulty with arousal, delayed or absent orgasm — the list goes on. It affects an estimated 40-65% of people taking SSRIs, and it's the number one reason people stop their antidepressant medication against medical advice.
PT-141 works through the melanocortin pathway, which is upstream of the serotonergic system that SSRIs affect. In practical terms: SSRIs dampen the desire signal. PT-141 amplifies it. They're not working against each other — PT-141 is simply providing a boost to a system that SSRIs have inadvertently suppressed.
This makes PT-141 one of the few options that can address SSRI-induced sexual dysfunction without requiring a change in antidepressant medication. Many users report that PT-141 effectively restores the sexual function they lost when they started their SSRI — without compromising the mental health benefits they're taking the SSRI for in the first place.
Pricing and Value
PT-141 at 10mg from Ascension Peptides typically runs around $50-55. Let's do the value calculation:
At a standard dose of 1.5mg per use, one 10mg vial provides approximately 6-7 uses. If you use it once a week, that's roughly 6-7 weeks of supply. At $50/vial, you're looking at roughly $7-8 per use.
For comparison: a single Viagra pill costs $30-70 at retail pharmacy without insurance. Generic sildenafil is cheaper ($2-10/pill through online pharmacies), but still — PT-141 is cost-competitive even with generic PDE5 inhibitors, and it does something fundamentally different.
Vyleesi (the branded, FDA-approved PT-141 product) costs approximately $900 for a box of 4 auto-injectors (1.75mg each) — that's $225 per use. The peptide version from Ascension, at roughly $7-8 per equivalent use, represents extraordinary value by comparison.
For a broader look at peptide sources, check our best peptide sources in 2026 roundup.
Who Should (and Shouldn't) Consider PT-141
Good candidates:
- People experiencing low desire (regardless of gender)
- Those who haven't responded well to PDE5 inhibitors
- SSRI users experiencing sexual side effects
- Post-menopausal women with decreased libido
- Anyone wanting an on-demand option that addresses desire, not just physical function
- People who can't use PDE5 inhibitors due to cardiovascular concerns or nitrate medications
Not ideal for:
- People with uncontrolled hypertension
- Those prone to severe nausea (though this can often be managed)
- Anyone looking for a daily-use solution (PT-141 works best used occasionally)
- People with purely vascular ED who respond well to Viagra/Cialis already
Frequently Asked Questions
References
- Clayton, A.H., et al. (2016). "Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trial." Women's Health, 12(3), 325-337. PubMed
- Kingsberg, S.A., et al. (2019). "Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials." Obstetrics & Gynecology, 134(5), 899-908. PubMed
- Diamond, L.E., et al. (2006). "An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist." Journal of Sexual Medicine, 3(4), 628-638. PubMed
- Safarinejad, M.R. (2008). "Evaluation of the safety and efficacy of bremelanotide, a melanocortin receptor agonist, in female subjects with arousal disorder." Journal of Sexual Medicine, 5(2), 434-444. PubMed
- Molinoff, P.B., et al. (2003). "PT-141: a melanocortin agonist for the treatment of sexual dysfunction." Annals of the New York Academy of Sciences, 994, 96-102. PubMed
- Rosen, R.C., et al. (2004). "Bremelanotide: a new approach to treatment of erectile dysfunction." International Journal of Impotence Research, 16, S56-S60. PubMed
- Pfaus, J.G., et al. (2007). "A role for melanocortins in sexual arousal." Current Pharmaceutical Design, 13(31), 3225-3232. PubMed